Full-Time

Senior Manager

Beef Customer Marketing

Deadline 8/28/26
Zoetis Services

Zoetis Services

10,001+ employees

Develops, manufactures, and sells animal vaccines

No salary listed

H1B Sponsorship Available

Kansas, USA + 13 more

More locations: North Dakota, USA | Iowa, USA | Texas, USA | South Dakota, USA | Mississippi, USA | Tennessee, USA | Arkansas, USA | Minnesota, USA | Nebraska, USA | Kentucky, USA | Oklahoma, USA | Missouri, USA | Louisiana, USA

Remote

More than 25% travel is required. Preferred location is Texas, with the role also available in the listed states.

Bachelor's, Master's, MBA

Category
Growth & Marketing (1)
Required Skills
Power BI
Market Research
Sales
Forecasting
Microsoft Windows
SAP Products
Word/Pages/Docs
Tableau
Excel/Numbers/Sheets
Microsoft Outlook
PowerPoint/Keynote/Slides

Get referred to Zoetis Services

See people who can refer or advise you

Requirements
  • A BA/BS degree in business or communications is required.
  • Seven to ten years of related commercial, marketing, sales, or cattle-industry experience is required.
  • Successful animal health sales experience is required; experience in the beef cattle industry is preferred.
  • Experience in animal health, pharmaceuticals, and/or agriculture is preferred.
  • Computer experience with Windows, Outlook, Word, PowerPoint, Excel, Acrobat Pro, and SAP is required.
  • Excellent marketing operations and marketing communications skills and knowledge are required.
  • A proven track record of sales success and an understanding of how to influence customer decision-making are required.
  • Demonstrated budget-management acumen is required.
  • Strong writing, editing, and verbal communication skills are required.
  • The ability to organize and prioritize multiple projects in a fast-paced environment and deliver high performance and quality on deadline is required.
  • The ability to provide innovative and efficient solutions that deliver programs and initiatives meeting marketing objectives and business strategies is required.
  • The ability to collaborate with and influence cross-functional teams is required.
  • The ability to think strategically and act decisively is required.
  • Initiative, resourcefulness, accountability, willingness to accept challenges, and the ability to lead change are required.
Responsibilities
  • Share market research to increase the industry acumen of customer partners and the internal team.
  • Build the beef market dashboard using Animalytix, MP Agrilytics, Tableau, Power BI, or comparable tools, and brief the Beef Marketing Team monthly.
  • Serve as the beef marketing PULSE expert by bringing insights from the field to marketing and vice versa.
  • Maintain an updated account of competitive programs and identify ways to position Zoetis against them.
  • Lead the production of literature, promotional items, advertising, and other materials for field marketing events.
  • Conduct and implement beef market research to provide knowledge and insights that drive strategy.
  • Collaborate with PAH on the development of Beef Optix and serve as the marketing representative for it.
  • Serve as the sales subject matter expert on the marketing team and collaborate with the field to ensure the value of marketing resources.
  • Own across-brand marketing and ensure alignment with field sales and technical services.
  • Increase the impact of BRD Solutions across the beef portfolio by bringing sales and marketing together, owning BRD Solutions strategy, and managing work with the marketing agency.
  • Work with the Associate Director of Livestock Customer Strategic Value to ensure data-driven customer engagement aligns with across-brand beef strategies.
  • Serve as the first line of contact for ABMs, TBMs, and Technical Service Veterinarians and Nutritionists requesting customer-facing marketing materials.
  • Work with the Retail team, Channel Marketing, and National Account Managers to identify pull-through opportunities, program strategies, and merchandising tactics through engagement with customers and IDSRs.
  • Use PULSE to build target lists and identify strategic opportunities.
  • Increase the impact of available resources across brands by working with field-force colleagues to deepen understanding and utilization of marketing materials and programs and their appropriate targeting.
  • Work with Sales, Marketing, Technical, and Learning & Development leadership to improve field-force execution and customer interactions by identifying and helping remove barriers.
  • Build value into Summer Sales Meetings, National Sales Meetings, and similar events.
  • Work cross-functionally with the Associate Director of Livestock Customer Strategic Value to leverage Value Added Services across the beef sales and marketing teams.
  • Develop processes for delivering persuasive technical knowledge to the field sales team.
  • Become the internal marketing expert and work across the portfolio with Marketing Managers and business-unit leaders to leverage customer insights effectively.
  • Oversee marketing-agency deliverables and other external suppliers to ensure partner capabilities, effectiveness, work, and resources meet team needs.
  • Work with the Marketing Communications team to manage the assigned A&P budget.
  • Formulate and implement long-term marketing strategy to drive in-line and launch Zoetis brand growth in targeted accounts.
  • Maintain industry awareness, monitor production-segment dynamics and competitive insights, communicate marketing strategy to field colleagues, increase utilization of marketing materials, and lead development of marketing resources as needed.
  • Remain current on beef-industry trends and share insights about their impacts on demand forecasts.
Desired Qualifications
  • An MBA or relevant advanced degree is preferred.
  • Experience in the beef cattle industry is preferred.
  • Experience in animal health, pharmaceuticals, and/or agriculture is preferred.

Zoetis creates medicines and vaccines to protect the health of companion animals and livestock. Its products include vaccines, anti-infectives, parasiticides, dermatology and other therapeutics, medicated feed additives, and diagnostics, sold through veterinarians, livestock producers, and pet owners. The company reaches customers in more than 100 countries and relies on big R&D and a global marketing network to bring new solutions to market. Its goal is to improve animal health worldwide by delivering science-based products and services that help care for animals and prevent disease.

Company Size

10,001+

Company Stage

IPO

Headquarters

Parsippany-Troy Hills, New Jersey

Founded

1952

Get referred to Zoetis Services

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Portela in Canada and the EU expands Zoetis' chronic-pain franchise beyond Solensia.
  • International revenue rose 6% in Q2 2026, offsetting U.S. companion-animal softness.
  • Livestock revenue rose 11% in Q2 2026, and diagnostics grew 12% despite market weakness.

What critics are saying

  • Zoetis cut 2026 revenue guidance to $9.12-$9.32 billion after Q2 2026 weakness.
  • U.S. companion-animal revenue fell 7% in Q2 2026 as Elanco and Merck pressured pricing.
  • If clinic visits stay weak through 2027, Zoetis loses share and valuation rerates lower.

What makes Zoetis Services unique

  • Zoetis launched Portela in July 2026, first three-month feline osteoarthritis antibody.
  • Zoetis owns broad global animal-health scale across 100 countries and two resilient end markets.
  • Zoetis combines veterinary science, biologics, and manufacturing control under Jay Saccaro since August 17.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

15%

1 year growth

15%

2 year growth

15%
Yahoo Finance
Aug 18th, 2026
Zoetis drops 40% in 2025 as Michael Burry bets on beaten-down animal health stock

Zoetis, an animal health company, has drawn attention from investor Michael Burry, who is long the stock according to Substack disclosures cited by media outlets. The shares have fallen roughly 40% this year and over 70% from their 2021 peak. Competition from Elanco and Merck in dermatology and parasite treatments has pressured results. In fiscal Q2 2026, revenue was roughly flat, with US sales down 7% whilst international revenue grew 6%. The stock now trades near 12 times forward earnings, compared with a historical average of 30 times. Zoetis maintains around 86% of the US pet skin drug market, with gross margins above 70%. Wall Street analysts remain mostly bullish, with consensus price targets suggesting roughly 70% upside potential.

Yahoo Finance
Aug 15th, 2026
Zoetis misses Q2 revenue target, slashes full-year guidance by 6.1% amid vet visit decline

Zoetis reported flat revenue of $2.47 billion in Q2, missing Wall Street estimates of $2.50 billion, though adjusted earnings per share of $1.87 slightly beat consensus. The animal health company faces intensifying competition in key Companion Animal categories and declining US veterinary clinic visits. CEO Kristin Peck noted that veterinary visits have declined across markets for multiple years, coinciding with price increases exceeding broader consumer inflation. The company's Livestock and Diagnostics segments showed resilience despite weakness in dermatology and parasiticides. Zoetis lowered its full-year revenue guidance to $9.22 billion from $9.82 billion, a 6.1% reduction, and cut adjusted EPS guidance to $6.20, down 10.5%. Operating margin fell to 37.4% from 39.1% year-on-year. Management indicated it is implementing temporary, targeted promotional actions rather than permanent price cuts to defend market share. Competitive pressures may persist into 2027.

Yahoo Finance
Aug 7th, 2026
Zoetis appoints GE Healthcare CFO Jay Saccaro as dual finance chief and COO

Zoetis has appointed former GE Healthcare CFO Jay Saccaro to a newly created dual role as CFO and chief operating officer, effective 17 August. Saccaro, who spent three years at GE Healthcare and nine years as CFO at Baxter International Healthcare, will receive an annual base salary of $1 million, with eligibility for bonuses totalling 100% of his salary and long-term incentives worth $5 million. He will also receive a one-time restricted stock unit award valued at approximately $6.2 million and a cash award of $1.2 million. Current CFO Wetteny Joseph will transition to special advisor on 16 August, remaining in a non-executive role until February 2027 or an earlier agreed date. The appointment comes as the New Jersey-based animal health company seeks new growth opportunities amid economic headwinds.

Yahoo Finance
Aug 7th, 2026
Zoetis Q2 earnings beat at $1.87 per share, revenues flat at $2.47B, 2026 outlook cut

Zoetis reported second-quarter 2026 adjusted earnings of $1.87 per share, beating the consensus estimate of $1.84. However, total revenues of $2.47 billion fell flat year over year and marginally missed expectations of $2.49 billion. US segment revenues declined 7% to $1.30 billion, driven by an 11% drop in companion animal product sales due to softer demand and increased competition. Livestock product sales in the US rose 23% to $222 million. International segment revenues increased 8% to $1.17 billion, supported by growth in parasiticides and livestock products. Zoetis cut its 2026 revenue guidance to $9.12-9.32 billion, reflecting expected operational growth of negative 1-3%. Year to date, shares have plunged 40%.

Yahoo Finance
Aug 6th, 2026
Zoetis revenue falls to $2.5B amid 6% drop in companion animal sales, livestock up 11%

Zoetis reported Q2 2026 revenue of $2.5 billion, flat year-over-year and down 1% on an organic operational basis. Adjusted diluted earnings per share rose 4% to $1.87, whilst adjusted net income fell 2% to $781 million. The animal health company's global companion animal revenue declined 6% to $1.7 billion, with key dermatology products down 16% to $395 million. However, livestock revenue grew 11% to $731 million, driven by demand in cattle and poultry. International markets provided growth momentum, with revenue up 6% to $1.2 billion, whilst US revenue fell 7% to $1.3 billion. Companion animal diagnostics revenue increased 12% to $118 million. For full-year 2026, Zoetis expects revenue of $9.12 billion to $9.32 billion and adjusted diluted EPS of $6.15 to $6.25.